By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asterand said today that it has won a contract from the National Institutes of Health valued at up to $24.3 million to support The Cancer Genome Atlas program.

Under the National Cancer Institute contract, which gives Asterand $5.4 million over a 17-month period and includes an option for renewal, the firm will supply clinically annotated human biospecimens to NCI for use in TCGA projects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.